Change of Expression of Ki 67, P53, and Cyclin D1 Immunoreactivity after Helicobacter pylori Eradication in Patients with Chronic Gastritis and Intestinal Metaplasia
Middle East Journal of Digestive Diseases · 31.10.2025 · 17 (4) · 282-286
DOI: 10.34172/mejdd.2025.444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Middle East Journal of Digestive Diseases, online erschienen am 31.10.2025. Verfasst von Seyed Mohammad Valizadeh Toosi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
We investigated the impact of Helicobacter pylori eradication on the expression of Ki67, p53, and cyclin D1 in patients diagnosed with chronic gastritis and intestinal metaplasia, utilizing the immunohistochemistry (IHC) method.
Methods
The immunoexpression of Ki67, p53, and cyclin D1 in the gastric mucosa was analyzed in 26 patients with chronic gastritis, intestinal metaplasia, and confirmed H. pylori infection, as well as 10 patients with normal gastric histology and no H. pylori infection. The assessments were performed both before and after H. pylori eradication.
Results
Successful eradication of H. pylori resulted in a significant reduction in the immunoexpression of Ki67, p53, and cyclin D1 in the majority of patients compared to pre-treatment. High immunoreactivity for Ki67, p53, and cyclin D1 was observed before eradication in 13 (50%), 4 (15.4%), and 9 (34.6%) patients, respectively. Following H. pylori eradication, none of the patients exhibited high immunoreactivity for these markers. Additionally, negative immunoreactivity for Ki67, p53, and cyclin D1 was noted in 21 (80.7%), 21 (80.7%), and 12 (46.1%) patients, respectively, with statistically significant P values of 0.005, 0.02, and 0.004.
Conclusion
The eradication of H. pylori in patients with chronic gastritis and intestinal metaplasia leads to a significant regression in the immunoreactivity of Ki67, p53, and cyclin D1. This suggests the potential for reversing precancerous changes in the gastric mucosa through timely treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Pathology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
ORCID-Profile: Seyed Mohammad Valizadeh Toosi, Somayeh Sheidaei
Zitieren
APA
Valizadeh Toosi, S. M., & Sheidaei, S. (2025). Change of Expression of Ki 67, P53, and Cyclin D1 Immunoreactivity after Helicobacter pylori Eradication in Patients with Chronic Gastritis and Intestinal Metaplasia. Middle East Journal of Digestive Diseases, 17(4), 282-286. https://doi.org/10.34172/mejdd.2025.444
Vancouver
Valizadeh Toosi SM, Sheidaei S. Change of Expression of Ki 67, P53, and Cyclin D1 Immunoreactivity after Helicobacter pylori Eradication in Patients with Chronic Gastritis and Intestinal Metaplasia. Middle East Journal of Digestive Diseases. 2025;17(4):282-286. doi:10.34172/mejdd.2025.444
BibTeX
@article{ValizadehToosi2025,
author = {Valizadeh Toosi, Seyed Mohammad and Sheidaei, Somayeh},
title = {Change of Expression of Ki 67, P53, and Cyclin D1 Immunoreactivity after Helicobacter pylori Eradication in Patients with Chronic Gastritis and Intestinal Metaplasia},
journal = {Middle East Journal of Digestive Diseases},
year = {2025},
volume = {17},
number = {4},
pages = {282--286},
doi = {10.34172/mejdd.2025.444}
}
EUVIMED